Improvement Project To Optimizing Nutrition With Higher Protein and Calorie Pediatric Tube Feeding

An Improvement Project Towards Optimizing Nutrition Intervention With a Higher Protein and Calorie Pediatric Tube Feeding Formula

This quality improvement project will include a practice change based on national guidelines for the nutritional management of PICU patients.

Study Overview

• Status: Completed
• Conditions: Critically Ill Children
• Intervention / Treatment: Other: Retrospective review of enteral tube feeding formula; Other: Peptide-based enteral formula

Detailed Description

This quality improvement project will include a practice change based on national guidelines for the nutritional management of PICU patients. The primary aim of this quality improvement project is to better meet protein needs of ICU critically ill children

• Study Type: Observational
• Enrollment (Actual): 28

Contacts and Locations

Study Locations

• United States
  • Illinois
    • Chicago, Illinois, United States, 60637
      • The University of Chicago, Comer Children's Hospital
  • Tennessee
    • Memphis, Tennessee, United States, 38103
      • Le Bonheur Children's Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 1 year to 13 years (CHILD)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Children aged 1-13 years with enteral feeding access

Description

Inclusion Criteria:

• Children aged 1-18 years old with enteral feeding access and anticipated to be fed for 5 days

Exclusion Criteria:

-

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
RFG; Retrospective review of enteral feeding in pediatric ICU patients for up to 5 days	Other: Retrospective review of enteral tube feeding formula; Enteral formula tube feeding will be retrospectively reviewed
PFG; Pediatric ICU population to be fed a peptide-based enteral formula with higher protein and higher calories for up to 5 days	Other: Peptide-based enteral formula; Peptide-based, higher protein and higher calorie enteral formula

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Enteral formula volume	Daily total formula volume (mL) delivered	5 days

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Protein modular	yes/no; if yes, dose (g/mL) and schedule	5 days
Enteral feeding interruptions	yes/no; if yes, reason for interruption	5 days
Diarrhea	yes/no; if yes, frequency in 24 hour period	5 days
Vomiting	yes/no; if yes, frequency in 24 hour period	5 days
Elevated gastric residuals	yes/no; if yes, amount (mL) in 24 hour period	5 days
Abdominal distention/pain	yes/no	5 days

Collaborators and Investigators

• Sponsor: Nestlé
• Investigators: Study Director: Krysmaru B AraujoTorres, MD, Nestlé

Study record dates

Study Major Dates

• Study Start (ACTUAL): January 15, 2018
• Primary Completion (ACTUAL): June 30, 2019
• Study Completion (ACTUAL): December 31, 2019

Study Registration Dates

• First Submitted: January 10, 2017
• First Submitted That Met QC Criteria: January 10, 2017
• First Posted (ESTIMATE): January 11, 2017

Study Record Updates

• Last Update Posted (ACTUAL): January 27, 2020
• Last Update Submitted That Met QC Criteria: January 23, 2020
• Last Verified: January 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Critical Illness
• Other Study ID Numbers: 16.04.US.HCN

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO